![Kyle Kurpinski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kyle Kurpinski
Direktor/Vorstandsmitglied bei Locus Biosciences, Inc.
Aktive Positionen von Kyle Kurpinski
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Locus Biosciences, Inc.
![]() Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Kyle Kurpinski
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 1 |
Sektoral
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Locus Biosciences, Inc.
![]() Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Technology Services |
- Börse
- Insiders
- Kyle Kurpinski
- Erfahrung